The article, published in the Journal of Hospital Medicine, found that large urban hospitals that serve as a safety net for patients with lower socioeconomic status, are at a disadvantage due to factors outside of their control.
Mandatory patient satisfaction surveys are one of the measures introduced by the Affordable Care Act to move away from the fee-for-service to a value-based healthcare system. CMS uses patient satisfaction scores to determine reimbursement levels to hospitals.
A team of researchers at Mount Sinai Health System, evaluated survey results from 3907 hospitals across the country and found that large health systems that serve population-dense urban regions with a patient population of lower socioeconomic status, fare worse on these surveys. The authors evaluated the data to identify statistical links between patients’ perceptions of their care and demographic factors outside the control of individual hospitals.
Two variables that had a high impact on the scores were hospital size and English as a second language. The authors went ahead and developed an adjustment formula to account for the inequities in the scores. “When this adjustment formula was applied to all New York State Hospitals, three large, urban academic medical centers — NY Presbyterian, Montefiore and Mount Sinai – moved into the top 10 in ranking,” according to one of the study authors. The article has been published in The Journal of Hospital Medicine.
Read the article on newswise: http://bit.ly/1HuSpl3
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More